Search Results

A mildly elevated CA19-9 marker triggered a cancer warning in an AI-assisted health screening report, but further medical evaluation ruled out pancreatic cancer.

Daraxonrasib nearly doubled survival in advanced pancreatic cancer, offering new hope for patients.

UCLA study finds treatment is safe, helps more patients reach surgery and reveals new insights into the tumor’s immune response.

Obesity hormone cholecystokinin linked to pancreatic cancer.

Learn about pancreatic cancer symptoms, PDAC vs NETs, risk factors, treatment pathways, and expert guidance from HPB surgeon Dr. Venkatesh BS.

Pancreatic cancer has one of the lowest survival rates. Dr. Soumya Somasekar breaks down the reasons for late diagnosis and the importance of risk awareness.